Uniprot ID: | |
Secondary ID: | |
Symbol: | miR-200a |
Other Name: | |
Class: | Epigenetics |
Type: | anti-fibrotic |
Molecular Function: |
Category I | Category II | Category III |
---|---|---|
Intracellular | Epigenetics | microRNA |
Reference Record 1
PubMed ID | 28846982 | Compound ID | |
CAS | Name | ||
Model | vitro | Fibrosis Disease | Cardiac fibrosis |
Process I | |||
Process II | EndMT | ||
Process III | |||
Mechanism | Targeting GRB2 |
Reference Record 2
PubMed ID | 28817830 | Compound ID | |
CAS | Name | ||
Model | vitro | Fibrosis Disease | Renal fibrosis |
Process I | |||
Process II | EMT | ||
Process III | |||
Mechanism | Targeting β-Catenin |
Reference Record 3
PubMed ID | 27819314 | Compound ID | |
CAS | Name | ||
Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | HSC proliferation | ||
Process III | |||
Mechanism | Targeting miR-200a |
Reference Record 4
PubMed ID | 26499180 | Compound ID | |
CAS | Name | ||
Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | EMT,HSCs proliferation | ||
Process III | |||
Mechanism | Targeting GLI family zinc finger 2 |
Reference Record 5
PubMed ID | 25049078 | Compound ID | |
CAS | Name | ||
Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | HSCs proliferation | ||
Process III | |||
Mechanism | Targeting Nrf2 |